Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments

Annals of Pharmacotherapy

Volumn 42, Issue 5, 2008, Pages 633-639

  Dale, Rita A ^a   Jensen, Lisa H ^a   Krantz, Mori J ^a  

^a Colorado Prevention Center ^*  (United States)

Author keywords

Framingham risk score; Point of care lipid testing

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANALYZER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION PREVENTION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIPID ANALYSIS; MALE; MEDICAL STAFF; NORMAL HUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; RISK ASSESSMENT;

EID: 42949173366     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K688     Document Type: Article

References (13)

1. Armor BL, Britton ML. Diabetes mellitus non-glucose monitoring: point of care testing. Ann Pharmacother 2004;38:1039-47. Epub 30 Apr 2004. DOI 10.1345/aph.1D247
2. Taylor JR, Lopez LM. Cholesterol: point-of-care testing. Ann Pharmacother 2004;38:1252-7. Epub 3 June 2004. DOI 10.1345/aph.1D269
3. Ford ES, Anjani UA, Croft JB, Critchley JA, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
4. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290:891-7.
5. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART study investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
6. Grundy SM, Cleeman JI, Merz CN, et al., for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.
7. Smith CS, Harbrejct M, Krantz MJ. A state consensus guideline for the prevention of cardiovascular disease in primary care settings. Crit Pathways Cardiol. In press.
8. Coronel SM, Krantz MJ. Medical therapy for symptomatic heart failure: a contemporary treatment algorithm. Crit Pathw Cardiol 2007;6:15-7.
9. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
10. Rosner B. Fundamentals of biostatistics. 4th ed. Harrisonburg, VA: Duxbury Press, 1995.
11. System user manual. Cholestech LDX. Hayward, CA: Cholestech Corporation, 2004.
12. CardioChek PA Point of Care Test System. Polymer Technology Systems 2006. www.cardiochek.com/professional/index2.asp (accessed 2007 Dec 14).
13. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.